Published Date: 12 Apr 2024
Abecma and Carvykti go to the second and third lines, respectively.
Read Full News1.
Researchers have determined that malignancy hibernation will be the next front in the fight against breast cancer.
2.
FDA Approves CAR-T Product Use for Myeloma Early.
3.
The Truth About Apple AirPods
4.
Using AI, one can find cancer risk factors.
5.
The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.
1.
From Birthmarks to Tumors: The Science Behind Infantile Hemangioma
2.
Modern Developments in Oncology for Specialists
3.
Exploring New Treatment Strategies for Mantle Cell Lymphoma
4.
CAR-T Therapy in Blood Cancers: Mechanisms, Efficacy, and Clinical Integration
5.
Innovative Advances in Oncology for Specialists
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V
3.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion
4.
Understanding the Role of Multidisciplinary Cancer Care
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation